- Home
- Fund
- Angel / Venture
- Inipharm Raises $35 Million in Series A…
Inipharm Raises $35 Million in Series A to Focus on Highly Validated Genetic Target HSD17B13
- Ethan Smith
- November 10, 2020
- 1
- 0 minute read
Most Popular
Recent Posts
- Ravencoin Mining Economics September 5, 2023
- KKR to Present at the Bernstein 39th Annual Strategic Decisions Conference 2023 July 6, 2023
- Restaurant365 Announces $135M Funding Round Co-Led by KKR and L Catterton July 6, 2023
- KKR Names Dan Pietrzak Global Head of Private Credit July 6, 2023
- KREST Names Julia Butler As Chief Investment Officer July 6, 2023